Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.88 USD | -2.50% | -6.70% | -47.84% |
05-15 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-22 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.84% | 588M | |
+10.15% | 114B | |
+12.72% | 107B | |
-5.50% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.39% | 17.51B | |
-39.36% | 17.17B | |
+6.60% | 14.14B | |
+34.81% | 12.2B |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- Transcript : Cabaletta Bio, Inc. Presents at Citi 18th Annual BioPharma Conference, Sep-07-2023 01